Publications by authors named "M S Highley"

Claim this Profile
A
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF mutant advanced melanoma (INTERIM).
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, Jenny Nobes, Ruth Board, Martin Highley

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, Gordon J S Rustin, Syed A Sohaib, Martin Highley

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Nitrogen Mustards.
Martin S Highley, Bart Landuyt, Hans Prenen, Peter G Harper, Ernst A De Bruijn

Pharmacol Rev· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
Stephane Oudard, Nadine Benhamouda, Bernard Escudier, Patrice Ravel, Thi Tran, Martin Highley

Cells· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
P G Corrie, A Marshall, P D Nathan, P Lorigan, M Gore, Martin Highley

Ann Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis